Hims & Hers Health, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the Annual Meeting of Stockholders held by Hims & Hers Health, Inc. on June 6, 2024. The filing details the voting outcomes for three proposals presented to shareholders of record as of April 16, 2024.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Results
Three proposals were voted upon at the Annual Meeting:
- Proposal 1 (Election of Directors): All eight nominees were elected. The voting was heavily influenced by the dual-class structure, where Class V shares carry 175 votes per share compared to one vote per Class A share. Total votes cast included significant "For" votes across all candidates, with Broker Non-Votes totaling 39,080,043 for each nominee.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. The vote was overwhelmingly in favor (1,598,597,458 For vs. 182,260 Against).
- Proposal 3 (Executive Compensation): Stockholders provided advisory approval of the Company's executive compensation. The proposal passed with 1,517,206,862 votes For, 42,457,770 Against, and 671,873 Abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items. The document is limited to the tabulation of votes.
Key Facts for Investors to Verify
- Confirmation of the dual-class voting structure impact, where Class V shares (8,377,623 shares) held significantly more voting power than Class A shares (206,271,215 shares).
- The specific identities of the eight directors elected to serve until the 2025 annual meeting.
- The ratification of KPMG LLP as the auditor for the 2024 fiscal year.
- The level of shareholder support for executive compensation, noting the number of "Against" votes (approx. 42.5 million) relative to the total votes cast.